Vaccine Renaissance Conference at the Institute for Immunology and Informatics
免疫学和信息学研究所疫苗复兴会议
基本信息
- 批准号:8130107
- 负责人:
- 金额:$ 0.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAreaAwarenessBioinformaticsBiotechnologyBioterrorismClinicCollaborationsCommunicable DiseasesCommunitiesDiseaseDoctor of MedicineEventGenomicsGrantHIVHealthHepatitis C virusHumanImmunologyIndustryInformaticsInstitutesLaboratoriesMalariaMeaslesMissionMumpsNamesParticipantPoliomyelitisPrincipal InvestigatorPublic HealthQuality of lifeRenaissanceResearchResearch PersonnelRhode IslandScientistSmallpoxTechniquesTerrorismTetanusTropical DiseaseUnited StatesUnited States National Institutes of HealthUniversitiesVaccine DesignVaccine ResearchVaccinesVirulentabstractingbasebiothreatdesigndrug discoveryexperienceglobal healthimprovedmeetingsneglectpandemic diseasepathogenpreventprogramsresearch and developmentsymposiumtherapeutic vaccinetoolvaccine development
项目摘要
DESCRIPTION (provided by applicant): Principal Investigator/Program Director (Last, first, middle): De Groot, Anne, S. Abstract Vaccines have had an enormous positive impact on global health saving literally millions of lives and preventing pandemics. Diseases such as polio, measles, mumps, tetanus and smallpox have nearly been eradicated by the use of vaccines. Now with the threat of global pandemics and bioterrorism there is an increased awareness of the value of vaccines. Given the global spread of infectious disease, the emergence of virulent new pathogens and the escalating threat of bio-terrorism, we propose to initiate a Vaccine Renaissance Conference. The Institute of Immunology and Informatics (I'Cubed) at the University of Rhode Island will host and organize a three-day conference for leading vaccine researchers and developers. This event will take place in October 2011, 2012, and 2013 in Providence, RI. The mission of the I'Cubed is to improve human and animal health by applying the power of immunomics --informatics, genomics and immunology -- to the design of better vaccines and therapeutics. The I'Cubed was founded by Annie De Groot, M.D. with a 13M dollar NIH U-19 grant to accelerate vaccine discovery in the areas of infectious diseases and bio-defense using state-of-the-art bioinformatics tools. The Institute is led by Dr. De Groot and Dr. Denice Spero, both highly experienced researchers and leaders in the field of drug discovery and both highly skilled at organizing scientific events. The primary objective of the 2011-2013 Vaccine Renaissance Conference is to provide a forum for the review of current progress in the research and development of vaccines, including new tools and techniques for accelerating vaccine discovery. The second objective of the meeting is to provide a networking opportunity for the vaccine R & D community nationwide, therefore creating important opportunities for collaborations between academic researchers and vaccine industry leaders. National and regional vaccine industry and academic leaders will be invited to speak about recent vaccine developments in their area of expertise. This Vaccine Renaissance Conference at the I'Cubed will follow three highly successful Vaccine Renaissance conferences which took place in 2004, 2006 and 2009 in Providence, Rhode Island. A fourth Conference is planned for October 2010. The global appeal of the Conference attracted more than 100 participants each year not only from the United States, but also from around the world.
PUBLIC HEALTH RELEVANCE: Principal Investigator/Program Director (Last, first, middle): De Groot, Anne, S. Narrative Vaccines are the single most important public health tool in saving lives. Vaccines improve the duration and quality of life and have the advantage of preventing diseases before they occur. Many diseases have been eradicated or nearly eradicated by the introduction and use of vaccines. However, there are diseases that have yet to be conquered and remain ripe for vaccine design- HIV, HCV, TB and Malaria to name a few. Given the global spread of infectious disease, the re-emergence of infectious diseases, the persistence of neglected tropical diseases, and the escalating threat of bio-terrorism, it is important for vaccine researchers to gather to discuss their latest research. To that end, the Institute for Immunology and Informatics at the University of Rhode Island proposes a three-day conference for leading vaccine researchers and producers. The conference will emphasize networking between academic researchers and representatives from vaccine-oriented biotechnology companies across the US and worldwide. This conference, "Vaccine Renaissance Conference at the Institute for Immunology and Informatics" will take place October 2011-2013 in Providence, Rhode Island.
描述(由申请人提供):首席调查员/计划主任(最后,第一,中间):de Groot,Anne,S。摘要疫苗对全球挽救全球健康的巨大积极影响,从字面上看数百万的生命并预防大流行病。使用疫苗,几乎可以消除脊髓灰质炎,麻疹,腮腺炎,破伤风和天花等疾病。现在,随着全球大流行和生物恐怖主义的威胁,人们对疫苗的价值的认识越来越高。鉴于传染病的全球传播,有毒的新病原体的出现以及生物恐怖主义的不断升级,我们建议启动疫苗文艺复兴时期会议。罗德岛大学的免疫学与信息学研究所(I'Cubed)将主持和组织为期三天的疫苗研究人员和开发人员会议。该活动将于2011年10月,2012年和2013年在RI普罗维登斯举行。 I'Cubed的使命是通过将免疫学(信息,基因组学和免疫学)的力量应用于更好的疫苗和治疗学的设计来改善人类和动物健康。 I'Cubed由医学博士Annie de Groot创立,并提供了1300万美元的NIH U-19赠款,可使用先进的生物信息学工具在传染病和生物防御领域加速疫苗。该研究所由De Groot博士和Denice Spero博士领导,他们都是经验丰富的研究人员和药物发现领域的领导者,并且都在组织科学事件方面擅长。 2011 - 2013年疫苗文艺复兴会议的主要目标是为审查疫苗研究和开发的当前进展提供一个论坛,包括新工具和技术,用于加速疫苗发现。会议的第二个目标是为全国的疫苗研发社区提供网络机会,因此为学术研究人员和疫苗行业领导者之间的合作创造了重要的机会。国家和区域疫苗行业和学术领导者将被邀请谈论其专业领域的最新疫苗开发。在I'Cubed举行的疫苗文艺复兴时期会议将遵循2004年,2006年和2009年在罗德岛州普罗维登斯(Providence)举行的三场非常成功的疫苗文艺复兴时期会议。计划于2010年10月举行第四次会议。该会议的全球吸引力不仅吸引了100多名参与者,不仅来自美国,而且还吸引了来自世界各地的参与者。
公共卫生相关性:首席调查员/计划主管(最后,第一,中间):de Groot,Anne,S。叙事疫苗是挽救生命的最重要的公共卫生工具。疫苗可以改善生活的持续时间和质量,并具有预防疾病发生之前的优势。通过引入和使用疫苗已经消除或几乎消除了许多疾病。但是,有一些疾病尚未被征服,并且仍然成熟,以供疫苗设计艾滋病毒,HCV,TB和疟疾等。鉴于传染病的全球传播,传染病的重新出现,被忽视的热带疾病的持续存在以及生物恐怖主义的威胁不断升级,疫苗研究人员对于聚集起来以讨论其最新研究很重要。为此,罗德岛大学的免疫学和信息学研究所提议为领先的疫苗研究人员和生产商举行为期三天的会议。该会议将强调学术研究人员与来自美国和全球范围内面向疫苗的生物技术公司的代表之间的网络。这次会议是“免疫学和信息学研究所的疫苗文艺复兴会议”将于2011年10月至2013年在罗德岛州的普罗维登斯举行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne Searls DeGroot其他文献
Anne Searls DeGroot的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne Searls DeGroot', 18)}}的其他基金
ISPRI-HCP: CHO protein impurity immunogenicity risk prediction for improving biosimilar product development and assessing product interchangeability
ISPRI-HCP:CHO 蛋白杂质免疫原性风险预测,用于改进生物仿制药产品开发和评估产品互换性
- 批准号:
10620080 - 财政年份:2022
- 资助金额:
$ 0.7万 - 项目类别:
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
CD4 T细胞记忆增强rHA H7N9流感疫苗的结构引导设计
- 批准号:
10216952 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
CD4 T细胞记忆增强rHA H7N9流感疫苗的结构引导设计
- 批准号:
9362529 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
CD4 T细胞记忆增强rHA H7N9流感疫苗的结构引导设计
- 批准号:
9978692 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease
基于新型抗原特异性免疫调节 Tregitope 的疗法可解决格雷夫斯病的自身免疫发病机制
- 批准号:
9410057 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza
针对隐形 H7N9 流感的无佐剂 VLP 疫苗的开发
- 批准号:
9304958 - 财政年份:2016
- 资助金额:
$ 0.7万 - 项目类别:
Inducing Tolerance to Enzyme Replacement Therapy for Pompe Disease
诱导对庞贝病酶替代疗法的耐受性
- 批准号:
8394488 - 财政年份:2012
- 资助金额:
$ 0.7万 - 项目类别:
Combined Factor VIII Replacement and Tolerance Therapy for Hemophilia A
A 型血友病联合因子 VIII 替代和耐受治疗
- 批准号:
8508305 - 财政年份:2012
- 资助金额:
$ 0.7万 - 项目类别:
Multi-intracellular Pathogen Epitope-based Vaccine
基于多细胞内病原体表位的疫苗
- 批准号:
8378738 - 财政年份:2012
- 资助金额:
$ 0.7万 - 项目类别:
相似国自然基金
区域医疗一体化对基层医疗机构合理用药的影响及优化策略——基于创新扩散理论
- 批准号:72304011
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
面向有限监督信息的脑影像感兴趣区域分割及应用
- 批准号:62376123
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
壳聚糖-没食子酸“共价牵手”协同焦磷酸盐“区域保护”调控肌原纤维蛋白凝胶特性的分子机制研究
- 批准号:32302110
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双区域自然对流耦合模型的高效数值方法研究
- 批准号:12361077
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
典型中小城市区域暴雨积水动态过程集合量化智能解析研究
- 批准号:52379008
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Mechanisms and Functions of Cortical Activity to Restore Behavior
皮层活动恢复行为的机制和功能
- 批准号:
10737217 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Inhaled Aerosol Dosimetry: Advances, Applications, and Impacts on Risk Assessments and Therapeutics
吸入气溶胶剂量测定:进展、应用以及对风险评估和治疗的影响
- 批准号:
10752525 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Multisensory integration and self-motion perception in primate vestibular cortex
灵长类动物前庭皮层的多感觉整合和自我运动感知
- 批准号:
10753017 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别: